Grayscale Sui Staking ETF reported net assets of $46.076 million as of September 30, 2026, a significant increase from $4.301 million at the end of 2025, driven by $33.7 million in net capital contributions and $8.067 million in net increase from operations. The Trust successfully uplisted to NYSE Arca on February 18, 2026, and began generating staking reward income, which totaled $246,000 for the first nine months of 2026.
Mobile Infrastructure Corp reported a net loss of $2.55 million for the quarter ended September 30, 2026, an improvement from a $6.43 million loss in the prior year period. Total revenues increased slightly to $9.58 million, driven by growth in managed property revenue, while total operating expenses decreased significantly due to lower depreciation and impairment charges.
For the third quarter of 2026, Grove Collaborative reported net revenue of $36.8 million and achieved a small net income of $0.1 million, a significant improvement from the $3.0 million net loss in the prior year period. The company reduced operating expenses across advertising and SG&A, though it continues to carry a total stockholders' deficit of $16.9 million.
Metagenomi Therapeutics, Inc. is an emerging growth company focused on genome editing technology, reporting 37,805,669 shares of common stock outstanding as of November 6, 2026. The filing highlights ongoing research and development programs, preclinical proof-of-concept goals, and risks related to macroeconomic volatility and regulatory developments.
QT Imaging Holdings reported significant revenue growth for the nine months ended September 30, 2026, reaching $21.3 million compared to $10.7 million in 2025. Despite this, the company incurred a net loss of $14.8 million, driven by increased operating expenses and a $8.3 million loss on debt extinguishment and modification.
SenesTech reported record third quarter 2026 revenue of $1.1 million, representing 59% year-over-year growth driven by a 337% surge in e-commerce sales. While gross profit reached a record $796,000 with a 72.6% margin, the company reported a net loss of $2.0 million for the quarter. Operational highlights include the expansion of the B2B sales team and the launch of new assessment and monitoring services for commercial customers.
For the nine months ended September 30, 2026, Grayscale Stellar Lumens Trust reported a net increase in net assets resulting from operations of $2.879 million, driven by $3.313 million in unrealized appreciation despite a net investment loss of $396,000. Total net assets grew to $26.848 million as of September 30, 2026, supported by capital share transactions and an increase in the Principal Market NAV per Share from $16.69 to $18.63.
QumulusAI, Inc. is a non-accelerated filer and emerging growth company that recently transitioned to public reporting, as evidenced by its 2026 filing. The company operates in the GPU-as-a-service and blockchain mining sectors, reporting significant risks including a history of losses, substantial indebtedness, and reliance on a single channel partner for GPU revenue.
For the nine months ended September 30, 2026, New Mountain Private Credit Fund reported total investment income of $144.4 million and net investment income of $71.5 million. The fund experienced significant net realized and unrealized losses totaling $56.2 million, resulting in a net increase in net assets from operations of $15.3 million, a decrease from $38.6 million in the prior year period.
Sky Harbour Group reported Q3 2026 financial results with consolidated revenues increasing 45% year-over-year. The company ended the quarter with $199.4 million in cash and U.S. Treasuries, plus $129.2 million in available capacity under its JP Morgan construction facility. Management also updated leasing progress, noting 92% occupancy at its Miami-Opa Locka campus and 101% economic occupancy at Dallas Addison Phase 1.
Micware Co., Ltd. reported a 3.4% increase in revenue to JPY10,612.7 million for the first half of fiscal year 2027, driven by growth in software-defined vehicle (SDV) projects. While gross profit rose 19.5% due to a shift toward higher-value upstream development, net income decreased 13.5% to JPY612.9 million, primarily due to one-time IPO-related share-based compensation and increased R&D investment in the DynaPlanet platform.
The Grayscale Solana Staking ETF reported a net increase in net assets of $62.576 million for the three months ended September 30, 2026, driven by significant unrealized appreciation. The Trust successfully transitioned to staking operations in 2026, generating $5.559 million in staking reward income year-to-date, while net assets grew to $213.466 million.
Gain Therapeutics reported a net loss of $13.4 million for the nine months ended September 30, 2026, with cash and cash equivalents decreasing to $11.7 million from $20.8 million at year-end 2025. The company highlighted its ongoing reliance on additional financing to support its Magellan™ platform and clinical development programs.
Firefly Aerospace reported Q3 2026 revenue of $110.7 million, a 259% year-over-year increase, driven by a record backlog of $1.7 billion. The company highlighted significant operational progress, including the expansion of its spacecraft cleanroom facility and the signing of major launch and technology contracts with AST SpaceMobile and Lockheed Martin.
Term
Q3 2026
“Firefly’s third quarter reflects the power of our diversified and vertically-integrated business. With five Moon missions running in parallel, Alpha Block II moving toward launch, SciTec executing on critical national security programs, and our strategic deal with AST SpaceMobile, we are converting our pipeline and backlog into results.”
B&G Foods reported total current assets of $772.6 million as of October 3, 2026, compared to $739.8 million at the start of the year. The company is actively exploring the divestiture of its Green Giant and Le Sieur businesses in Canada to reduce long-term debt and improve margins.
Palisade Bio reported a net loss of $34.8 million for the nine months ended September 30, 2026, compared to $7.9 million in the prior year, driven by a significant increase in research and development expenses. The company maintained a cash position of $113.6 million and generated $0.5 million in license revenue during the period.
Fossil Group reported Q3 2026 net sales of $271.2 million, a 0.4% increase, with gross margin expanding significantly by 10.8 percentage points to 59.8%. The company achieved operating income of $25 million and raised its full-year 2026 financial outlook based on strong year-to-date performance and product innovation momentum.
Term
Q3 2026
“Our strong third quarter results reflect momentum across brands, channels and geographies and demonstrate that our product innovation and storytelling is connecting with consumers around the globe.”
Franco Fogliato, CEO
“The three strategic pillars under our turnaround plan are translating to top line growth and accelerating profitability. We are pleased that year-to-date results are outpacing our expectations, supporting an increase in our full year financial outlook on both the top and bottom line.”
National CineMedia reported Q3 2026 financial results, with revenue decreasing 3.2% to $61.4 million and a net loss of $17.2 million. The company completed its acquisition of Captivate during the quarter, expanding its digital screen network to 48,000 across theaters and residential/office properties. Additionally, the company announced the planned retirement of CEO Tom Lesinski.
Term
Q3 2026
“With Captivate now part of NCM, we have significantly expanded our reach, diversified our advertising offerings and created new opportunities to connect brands with highly engaged audiences where they work, live and play. We are encouraged by early fourth-quarter trends across both networks, supported by a strong holiday theatrical slate and growing demand for Captivate’s office and residential inventory. Looking ahead, we remain focused on successfully integrating Captivate, realizing acquisition synergies and reducing leverage to drive sustainable growth and long-term value for our shareholders. As I prepare to retire, I am incredibly proud of what we have accomplished together and confident in NCM's future”
Tom Lesinski, Chief Executive Officer of National CineMedia, Inc.
Dermata Therapeutics transitioned from a prescription R&D focus to a direct-to-consumer skincare brand, launching its first Tome product in August 2026. For the nine months ended September 30, 2026, the company reported a net loss of $7.6 million on initial sales of $74,137, with cash reserves decreasing to approximately $4.8 million.
Evolv Technologies reported Q3 2026 revenue of $47.3 million, a 10% increase year-over-year, and ending Annual Recurring Revenue (ARR) of $140.5 million. The company posted a net loss of $15.6 million for the quarter while achieving positive Adjusted EBITDA of $4.7 million. Management highlighted strong net revenue retention and progress toward a long-term growth model despite a challenging prior-year comparison.
Term
Q3 2026
“Our third-quarter results reflect the significant progress we have made building a stronger, more scalable and increasingly predictable business. We delivered double-digit revenue growth, with ARR growing faster than revenue, against a challenging prior-year comparison, as last year's results included the largest contract in our history.”
John Kedzierski, President and Chief Executive Officer
Grayscale Litecoin Trust reported a significant increase in net assets from operations of $47.3 million for the quarter ended September 30, 2026, driven primarily by $48.5 million in unrealized appreciation of LTC. The Trust's Principal Market NAV per Share rose from $3.39 to $5.35 during the period, while the total number of outstanding shares remained constant at 24,252,100.
Electromed reported its 16th consecutive quarter of year-over-year revenue and operating income growth for the fiscal first quarter ended September 30, 2026. Net revenues increased 10.6% to $18.7 million, driven by strong performance in the core homecare market, while net income rose 29.3% to $2.8 million. The company remains debt-free and returned $4.3 million to shareholders through share repurchases during the quarter.
Term
Q1 2027
“We delivered our 16th consecutive quarter of year-over-year revenue and operating income growth, with double-digit revenue growth, a 30.7% increase in operating income and an 80.0% gross margin—demonstrating the strength of our direct-to-patient model and operating leverage. We also returned $4.3 million to shareholders through share repurchases while remaining debt-free. With a strong balance sheet and high-performing sales and fulfillment teams, Electromed is well positioned to bring SmartVest® therapy to more patients who need to breathe easier.”
Jim Cunniff, President and Chief Executive Officer
Gladstone Land reported its Q3 2026 financial results, highlighting a significant increase in participation rent revenue to $16.8 million compared to $5.4 million in the prior-year quarter. The results were driven by strong pricing for almonds and pistachios, including a 67% increase in the initial base price for the 2026 pistachio crop.
Silicon Laboratories reported Q3 2026 revenue of $251 million, a 22% year-over-year increase driven by record medical revenue and broad-based growth in Industrial & Commercial and Home & Life segments. GAAP diluted EPS improved to $0.26 from a loss in the prior year, while non-GAAP EPS rose 228% to $1.05. The company suspended forward-looking guidance due to its pending acquisition by Texas Instruments.
Term
Q3 2026
“We delivered strong third-quarter results, with revenue up 10% sequentially, underpinned by broad-based growth across many end applications and another record quarter for medical revenue as known customer ramps continued. Earnings significantly outpaced revenue growth, a result of strong operational execution by the team. Looking ahead, our current backlog and design-win ramps position us for continued revenue growth and meaningful earnings expansion.”
Matt Johnson, President and Chief Executive Officer
Rigetti Computing reported total assets of $623.9 million as of September 30, 2026, a decrease from $666.6 million at year-end 2025. The company maintains a strong liquidity position with $45.8 million in cash and $337.5 million in short-term investments, while common stock outstanding reached 342,783,018 shares as of November 6, 2026.
Orion180 Insurance Group Inc. reported significant growth for the nine months ended September 30, 2026, with total revenues increasing to $134.0 million from $84.5 million in the prior year. The company successfully completed its initial public offering during the third quarter, raising $224.4 million in net proceeds, which contributed to a substantial increase in total assets to $936.9 million.
Grocery Outlet reported a net loss of $161.4 million for the 39 weeks ended October 3, 2026, primarily driven by a $158.0 million goodwill impairment charge and $20.1 million in restructuring charges. Despite these non-cash and one-time costs, net sales for the period grew slightly to $3.54 billion compared to $3.47 billion in the prior year period.
Gevo reported record third quarter 2026 financial results, driven by its carbon business and the sale of Canadian Clean Fuel Regulation (CFR) credits. The company achieved net income of $23 million and record revenue of $83 million, significantly improving its cash position to $68 million.
Term
Q3 2026
“The quarter marked our strongest financial performance to date, with record revenue, net income, Adjusted EBITDA and cash flow from operations. We said we would build a carbon business that stands on its own in 2026. These results show it’s working.”
Paul Bloom, Chief Executive Officer
“Gevo has a powerful growth platform built on low-carbon fuels, carbon and maximizing incentives. We have focused development around our existing operations, improving margins and near-term cash flow, with a portfolio of growth projects we believe will create substantial shareholder value.”
Anterix Inc. reported spectrum revenue of $3.9 million for the six months ended September 30, 2026, up from $3.0 million in the prior year. The company maintained a strong liquidity position with $107.5 million in cash and cash equivalents, while continuing to execute its strategy of commercializing 900 MHz spectrum assets for utility and critical infrastructure customers.
Janus International Group reported a net loss of $13.3 million for the third quarter of 2026, compared to a net income of $15.2 million in the prior year period, primarily driven by an $18.3 million impairment charge and higher cost of revenues. Total revenues for the quarter decreased slightly to $213.1 million from $219.3 million, while the company continued its share repurchase program, increasing treasury stock to $145.6 million.